Pizzurro Gabriela A, Bridges Kate, Jiang Xiaodong, Vidyarthi Aurobind, Miller-Jensen Kathryn, Colegio Oscar R
Department of Biomedical Engineering, School of Engineering and Applied Science, Yale University, New Haven, CT 06511, USA.
Department of Immunobiology, School of Medicine, Yale University, New Haven, CT 06511, USA.
Cancers (Basel). 2023 Jun 24;15(13):3330. doi: 10.3390/cancers15133330.
Tumor-associated macrophages (TAMs) can be widely heterogeneous, based on their ontogeny and function, and driven by the tissue-specific niche. TAMs are highly abundant in the melanoma tumor microenvironment (TME), usually correlating with worse prognoses. However, the understanding of their diversity may be harnessed for therapeutic purposes. Here, we used the clinically relevant YUMM1.7 model to study melanoma TAM origin and dynamics during tumor progression. In i.d. YUMM1.7 tumors, we identified distinct TAM subsets based on F4/80 expression, with the F4/80 fraction increasing over time and displaying a tissue-resident-like phenotype. While skin-resident macrophages showed mixed ontogeny, F4/80 TAM subsets in the melanoma TME originated almost exclusively from bone-marrow precursors. A multiparametric analysis of the macrophage phenotype showed a temporal divergence of the F4/80 TAM subpopulations, which also differed from the skin-resident subsets and their monocytic precursors. Overall, the F4/80 TAMs displayed co-expressions of M1- and M2-like canonical markers, while RNA sequencing showed differential immunosuppressive and metabolic profiles. Gene-set enrichment analysis (GSEA) revealed F4/80 TAMs to rely on oxidative phosphorylation, with increased proliferation and protein secretion, while F4/80 cells had high pro-inflammatory and intracellular signaling pathways, with lipid and polyamine metabolism. Overall, we provide an in-depth characterization of and compelling evidence for the BM-dependency of melanoma TAMs. Interestingly, the transcriptomic analysis of these BM-derived TAMs matched macrophage subsets with mixed ontogeny, which have been observed in other tumor models. Our findings may serve as a guide for identifying potential ways of targeting specific immunosuppressive TAMs in melanoma.
肿瘤相关巨噬细胞(TAM)基于其个体发育和功能可能具有广泛的异质性,并受组织特异性微环境驱动。TAM在黑色素瘤肿瘤微环境(TME)中高度丰富,通常与较差的预后相关。然而,对其多样性的理解可用于治疗目的。在这里,我们使用临床相关的YUMM1.7模型来研究黑色素瘤TAM在肿瘤进展过程中的起源和动态变化。在皮下YUMM1.7肿瘤中,我们基于F4/80表达鉴定出不同的TAM亚群,F4/80部分随时间增加并表现出类似组织驻留的表型。虽然皮肤驻留巨噬细胞显示出混合的个体发育,但黑色素瘤TME中的F4/80 TAM亚群几乎完全起源于骨髓前体。对巨噬细胞表型的多参数分析显示F4/80 TAM亚群存在时间上的差异,这也与皮肤驻留亚群及其单核细胞前体不同。总体而言,F4/80 TAM显示出M1和M2样经典标志物的共表达,而RNA测序显示出不同的免疫抑制和代谢谱。基因集富集分析(GSEA)显示F4/80 TAM依赖氧化磷酸化,增殖和蛋白质分泌增加,而F4/80细胞具有高促炎和细胞内信号通路,以及脂质和多胺代谢。总体而言,我们为黑色素瘤TAM对骨髓的依赖性提供了深入的表征和令人信服的证据。有趣的是,这些源自骨髓的TAM的转录组分析与在其他肿瘤模型中观察到的具有混合个体发育的巨噬细胞亚群相匹配。我们的发现可能为识别靶向黑色素瘤中特定免疫抑制TAM的潜在方法提供指导。